Rivastigmine for Dementia Associated with Parkinson's Disease
2004· article· en· New England Journal of Medicine· Medicine
aff
1,217
citations
Works
Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.
Route
Field
Type
Language
Year range
to
Screen consensus
Sort
Flags
Screening evidence
Direct labels are sparse and unvalidated. Missing labels are unknown.
1 filter active
513 workspage 1 of 21
Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials
2004· article· en· Archives of Neurology· Medicine
aboutno aff
971
citations
Nonpharmacological Therapies in Alzheimer’s Disease: A Systematic Review of Efficacy
2010· review· en· Dementia and Geriatric Cognitive Disorders· Medicine
aff
925
citations
Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
2008· review· en· Annals of Internal Medicine· Medicine
aff
777
citations
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial
2002· article· en· The Lancet· Biochemistry, Genetics and Molecular Biology
affno abstract
761
citations
Treatment of Alzheimer's disease; current status and new perspectives
2003· article· en· The Lancet Neurology· Medicine
affno abstract
725
citations
Clinical trials and late‐stage drug development for <scp>A</scp>lzheimer's disease: an appraisal from 1984 to 2014
2014· review· en· Journal of Internal Medicine· Medicine
aff
641
citations
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
2000· article· en· BMJ· Chemistry
aboutno aff
629
citations
To: A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease
2001· article· en· Neurology· Medicine
aboutno aff
491
citations
Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment
2004· article· en· Journal of Clinical Investigation· Medicine
fundno aff
429
citations
Efficacy and Tolerability of Donepezil in Vascular Dementia
2003· article· en· Stroke· Medicine
afffund
385
citations
Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research
2019· review· en· The Journal of Prevention of Alzheimer s Disease· Medicine
afffund
355
citations
Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians
2008· article· en· Annals of Internal Medicine· Medicine
aff
350
citations
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study
2007· article· en· The Lancet Neurology· Medicine
affno abstract
337
citations
Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine
2014· review· en· Expert Opinion on Drug Safety· Medicine
aff
301
citations
Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial
2001· article· en· Journal of Neurology Neurosurgery & Psychiatry· Medicine
affabout
283
citations
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.
2003· article· en· PubMed· Medicine
aff
266
citations
Donepezil preserves cognition and global function in patients with severe Alzheimer disease
2007· article· en· Neurology· Medicine
aff
253
citations
Emerging Therapies for Vascular Dementia and Vascular Cognitive Impairment
2004· article· en· Stroke· Neuroscience
aff
235
citations
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period
2005· article· en· Current Medical Research and Opinion· Medicine
aff
230
citations
Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer’s Disease
2002· article· en· International Psychogeriatrics· Medicine
aff
230
citations
Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis
2007· article· en· International Journal of Geriatric Psychiatry· Health Professions
aff
219
citations
Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis
2013· review· en· Canadian Medical Association Journal· Neuroscience
afffundvenue
210
citations
Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies
2005· review· en· International Journal of Geriatric Psychiatry· Medicine
aff
207
citations
Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden
2003· article· en· Journal of the American Geriatrics Society· Medicine
aff
203
citations